Table 2

Logistic regression analysis for the risk of all-cause mortality among the access flow groups within 1 year

AnalysisAll-cause mortality
OR (95% CI)p Value
 Access flow ≥1000 mL/min1 (reference)
 Access flow <1000 mL/min3.41 (1.37 to 8.47)0.008
 Access flow ≥1000 mL/min1 (reference)
 Access flow <1000 mL/min6.04 (1.64 to 22.16)0.007
  • *Adjusted for age; sex; diabetes mellitus; CAD; CHF; CVA; COPD; liver cirrhosis; malignancy; systolic blood pressure; diastolic blood pressure; haemodialysis vintage; vascular access type; ESRD causes; cardiac index; haemoglobin, albumin, cholesterol, ferritin, sodium, potassium, ionised calcium, phosphate and parathyroid hormone levels; Kt/V; and ESA dosage.

  • CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; ESA, erythropoiesis-stimulating agent; ESRD, end-stage renal disease.